Menu
1-702-720-6310 info@microcapspecualtors.com

The Next Target in Biotech Land – TheStreet.com

The Next Target in Biotech Land
TheStreet.com
Johnson & Johnson (JNJ) finally wrapped up its months-long pursuit of Europe’s largest biotech concern this week. It will buy Actelion for some $30 billion using cash “stranded” in its overseas operations. It is the largest M&A deal so far across the

Search